Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Two large trials support use of alteplase accelerated infusion for acute MI

Oct. 20, 1997

No Comments

Staphylokinase vs. alteplase for thrombolysis in rabbit stroke model

Oct. 16, 1997

No Comments

Hirudin more effective than heparin in heart attack patients

Oct. 15, 1997

No Comments

New antithrombotics/anticoagulants synthesized at Zeneca

Oct. 14, 1997

No Comments

KBT-3022: pharmacokinetics and pharmacological effects in guinea pigs

Oct. 13, 1997

No Comments

Merck's new fibrinogen receptor antagonists

Oct. 9, 1997

No Comments

Mitsui Toatsu's antiplatelet agent slated to enter clinical testing

Oct. 6, 1997

No Comments

Neutralase proceeds to phase III trials

Oct. 3, 1997

No Comments

Cor Therapeutics submits NDA amendment for Integrilin to FDA

Oct. 2, 1997

No Comments

Clinical results presented for Knoll's PEG-hirudin

Sep. 30, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Hematologic
RSS

Two large trials support use of alteplase accelerated infusion for acute MI

Staphylokinase vs. alteplase for thrombolysis in rabbit stroke model

Hirudin more effective than heparin in heart attack patients

New antithrombotics/anticoagulants synthesized at Zeneca

KBT-3022: pharmacokinetics and pharmacological effects in guinea pigs

Merck's new fibrinogen receptor antagonists

Mitsui Toatsu's antiplatelet agent slated to enter clinical testing

Neutralase proceeds to phase III trials

Cor Therapeutics submits NDA amendment for Integrilin to FDA

Clinical results presented for Knoll's PEG-hirudin

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection

Hematologic RSS

Hematologic
RSS